| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peroxisomal Disorders | 5 | 2023 | 13 | 2.240 |
Why?
|
| Drosophila melanogaster | 20 | 2025 | 772 | 2.200 |
Why?
|
| Peroxisomes | 7 | 2020 | 36 | 2.020 |
Why?
|
| Neurodevelopmental Disorders | 12 | 2025 | 501 | 1.980 |
Why?
|
| Intellectual Disability | 18 | 2025 | 1054 | 1.890 |
Why?
|
| Mutation, Missense | 18 | 2025 | 879 | 1.820 |
Why?
|
| Developmental Disabilities | 14 | 2025 | 715 | 1.770 |
Why?
|
| Adrenoleukodystrophy | 2 | 2023 | 8 | 1.610 |
Why?
|
| Zellweger Syndrome | 4 | 2024 | 15 | 1.590 |
Why?
|
| Drosophila | 16 | 2024 | 776 | 1.560 |
Why?
|
| Phenotype | 30 | 2025 | 4270 | 1.170 |
Why?
|
| Mutation | 24 | 2023 | 5906 | 1.110 |
Why?
|
| Drosophila Proteins | 13 | 2024 | 714 | 1.110 |
Why?
|
| Autism Spectrum Disorder | 6 | 2022 | 392 | 1.090 |
Why?
|
| Rare Diseases | 7 | 2023 | 191 | 1.050 |
Why?
|
| Dynamins | 3 | 2019 | 39 | 0.900 |
Why?
|
| Genetic Testing | 7 | 2024 | 1016 | 0.890 |
Why?
|
| Genetic Diseases, Inborn | 5 | 2019 | 442 | 0.850 |
Why?
|
| Vulnerable Populations | 2 | 2024 | 136 | 0.830 |
Why?
|
| Abnormalities, Multiple | 7 | 2022 | 960 | 0.780 |
Why?
|
| GTP Phosphohydrolases | 3 | 2019 | 147 | 0.750 |
Why?
|
| Heterozygote | 8 | 2025 | 672 | 0.750 |
Why?
|
| Intestinal Pseudo-Obstruction | 3 | 2019 | 31 | 0.740 |
Why?
|
| Actins | 4 | 2023 | 346 | 0.740 |
Why?
|
| Histones | 3 | 2023 | 542 | 0.730 |
Why?
|
| Arginine | 2 | 2020 | 335 | 0.700 |
Why?
|
| Lysosomal Storage Diseases | 2 | 2018 | 36 | 0.700 |
Why?
|
| Brain Diseases | 2 | 2020 | 299 | 0.650 |
Why?
|
| Animals | 39 | 2025 | 34304 | 0.650 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2020 | 291 | 0.640 |
Why?
|
| Seizures | 5 | 2022 | 868 | 0.640 |
Why?
|
| Genes, Insect | 1 | 2020 | 123 | 0.640 |
Why?
|
| beta Catenin | 1 | 2020 | 215 | 0.640 |
Why?
|
| Humans | 86 | 2025 | 125110 | 0.630 |
Why?
|
| Mitochondria | 5 | 2020 | 680 | 0.620 |
Why?
|
| Mitochondrial Proteins | 3 | 2018 | 228 | 0.620 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 1 | 2018 | 9 | 0.590 |
Why?
|
| Alleles | 9 | 2024 | 1615 | 0.590 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2018 | 247 | 0.590 |
Why?
|
| Exome | 10 | 2024 | 1034 | 0.580 |
Why?
|
| Mitochondrial Dynamics | 1 | 2018 | 44 | 0.570 |
Why?
|
| Urinary Bladder | 3 | 2019 | 242 | 0.560 |
Why?
|
| Spasms, Infantile | 2 | 2017 | 172 | 0.550 |
Why?
|
| Carbohydrate Metabolism | 1 | 2017 | 57 | 0.550 |
Why?
|
| Beckwith-Wiedemann Syndrome | 3 | 2005 | 16 | 0.540 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2017 | 104 | 0.520 |
Why?
|
| Colon | 3 | 2019 | 352 | 0.520 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2024 | 3175 | 0.510 |
Why?
|
| Nervous System Malformations | 3 | 2022 | 130 | 0.480 |
Why?
|
| Genetic Research | 1 | 2015 | 55 | 0.450 |
Why?
|
| Amino Acid Sequence | 9 | 2021 | 2717 | 0.440 |
Why?
|
| Zebrafish | 6 | 2023 | 380 | 0.440 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2013 | 27 | 0.420 |
Why?
|
| Biomarkers | 2 | 2023 | 3105 | 0.420 |
Why?
|
| Membrane Proteins | 8 | 2024 | 1538 | 0.410 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2013 | 37 | 0.410 |
Why?
|
| Genomics | 6 | 2024 | 1520 | 0.410 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 4408 | 0.410 |
Why?
|
| Intestinal Neoplasms | 1 | 2013 | 40 | 0.410 |
Why?
|
| Child, Preschool | 21 | 2025 | 14151 | 0.390 |
Why?
|
| Pedigree | 10 | 2025 | 1610 | 0.390 |
Why?
|
| Musculoskeletal Abnormalities | 2 | 2024 | 70 | 0.380 |
Why?
|
| Male | 38 | 2025 | 61443 | 0.380 |
Why?
|
| Peroxiredoxins | 1 | 2011 | 9 | 0.370 |
Why?
|
| Presenilins | 1 | 2011 | 8 | 0.370 |
Why?
|
| Microcephaly | 3 | 2024 | 331 | 0.370 |
Why?
|
| Loss of Function Mutation | 5 | 2024 | 150 | 0.370 |
Why?
|
| Genome-Wide Association Study | 3 | 2017 | 1694 | 0.360 |
Why?
|
| Congenital Abnormalities | 2 | 2025 | 257 | 0.360 |
Why?
|
| Female | 38 | 2025 | 66704 | 0.360 |
Why?
|
| Child | 25 | 2025 | 24609 | 0.350 |
Why?
|
| Intestine, Small | 1 | 2013 | 310 | 0.350 |
Why?
|
| Inheritance Patterns | 2 | 2014 | 127 | 0.340 |
Why?
|
| Autistic Disorder | 3 | 2022 | 349 | 0.340 |
Why?
|
| Transcription Factors | 6 | 2024 | 2603 | 0.330 |
Why?
|
| Genetic Variation | 5 | 2021 | 1505 | 0.330 |
Why?
|
| Receptors, Notch | 1 | 2011 | 205 | 0.320 |
Why?
|
| Infant | 17 | 2025 | 12609 | 0.320 |
Why?
|
| Mediator Complex | 2 | 2021 | 52 | 0.320 |
Why?
|
| Adult | 21 | 2024 | 29460 | 0.320 |
Why?
|
| Syndrome | 9 | 2024 | 1119 | 0.310 |
Why?
|
| Neurofibromin 1 | 2 | 2019 | 42 | 0.310 |
Why?
|
| Language Development Disorders | 3 | 2022 | 175 | 0.310 |
Why?
|
| Metabolic Diseases | 2 | 2022 | 130 | 0.300 |
Why?
|
| Neurofibromatosis 1 | 2 | 2019 | 63 | 0.290 |
Why?
|
| Adolescent | 14 | 2024 | 19414 | 0.290 |
Why?
|
| Nervous System Diseases | 2 | 2023 | 373 | 0.280 |
Why?
|
| Genetic Association Studies | 3 | 2019 | 780 | 0.280 |
Why?
|
| Zinc Fingers | 3 | 2025 | 119 | 0.280 |
Why?
|
| Infant, Newborn | 11 | 2023 | 8275 | 0.270 |
Why?
|
| Repressor Proteins | 2 | 2025 | 827 | 0.260 |
Why?
|
| Metabolomics | 2 | 2022 | 422 | 0.260 |
Why?
|
| Muscles | 2 | 2019 | 292 | 0.260 |
Why?
|
| Cerebellum | 2 | 2021 | 441 | 0.260 |
Why?
|
| Epilepsy | 4 | 2022 | 873 | 0.260 |
Why?
|
| Young Adult | 10 | 2024 | 9056 | 0.250 |
Why?
|
| Gain of Function Mutation | 2 | 2023 | 108 | 0.250 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 2 | 2023 | 67 | 0.250 |
Why?
|
| Genetic Heterogeneity | 1 | 2005 | 127 | 0.230 |
Why?
|
| Polyneuropathies | 1 | 2024 | 29 | 0.230 |
Why?
|
| Paraganglioma | 1 | 2024 | 20 | 0.230 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2024 | 7 | 0.230 |
Why?
|
| Craniofacial Abnormalities | 3 | 2021 | 239 | 0.230 |
Why?
|
| Homozygote | 2 | 2024 | 547 | 0.220 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2024 | 144 | 0.220 |
Why?
|
| Muscle Hypotonia | 4 | 2022 | 187 | 0.220 |
Why?
|
| Neuroglia | 3 | 2020 | 207 | 0.220 |
Why?
|
| DNA-Binding Proteins | 5 | 2022 | 2061 | 0.210 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2023 | 27 | 0.210 |
Why?
|
| Hemiplegia | 1 | 2023 | 45 | 0.210 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 89 | 0.210 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2023 | 63 | 0.210 |
Why?
|
| Retinitis Pigmentosa | 1 | 2024 | 84 | 0.210 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2024 | 140 | 0.200 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2022 | 212 | 0.200 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 199 | 0.200 |
Why?
|
| Genome, Human | 3 | 2021 | 1293 | 0.200 |
Why?
|
| Channelopathies | 1 | 2022 | 12 | 0.190 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2023 | 161 | 0.190 |
Why?
|
| Receptors, Glycine | 1 | 2022 | 16 | 0.190 |
Why?
|
| Dystonia | 2 | 2021 | 171 | 0.190 |
Why?
|
| Micrognathism | 1 | 2022 | 65 | 0.190 |
Why?
|
| Neurobiology | 1 | 2021 | 25 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 1762 | 0.190 |
Why?
|
| Amino Acid Substitution | 2 | 2019 | 398 | 0.190 |
Why?
|
| beta Karyopherins | 1 | 2021 | 12 | 0.190 |
Why?
|
| Hand Deformities, Congenital | 1 | 2022 | 89 | 0.180 |
Why?
|
| Growth Differentiation Factors | 1 | 2021 | 11 | 0.180 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 234 | 0.180 |
Why?
|
| ran GTP-Binding Protein | 1 | 2021 | 28 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2022 | 472 | 0.180 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2021 | 33 | 0.180 |
Why?
|
| Karyopherins | 1 | 2021 | 36 | 0.180 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2021 | 35 | 0.180 |
Why?
|
| Ataxia Telangiectasia | 1 | 2021 | 15 | 0.180 |
Why?
|
| X Chromosome | 2 | 2020 | 338 | 0.180 |
Why?
|
| Signal Transduction | 2 | 2024 | 4597 | 0.180 |
Why?
|
| Calcium Channels | 2 | 2022 | 160 | 0.180 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2021 | 190 | 0.170 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2021 | 100 | 0.170 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 125 | 0.170 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2020 | 9 | 0.170 |
Why?
|
| Pregnancy Complications | 1 | 2005 | 515 | 0.170 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2020 | 8 | 0.170 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 61 | 0.160 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2020 | 89 | 0.160 |
Why?
|
| Abdominal Neoplasms | 1 | 2020 | 32 | 0.160 |
Why?
|
| Fibroblasts | 1 | 2024 | 887 | 0.160 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 59 | 0.160 |
Why?
|
| Metalloendopeptidases | 2 | 2017 | 101 | 0.160 |
Why?
|
| WD40 Repeats | 1 | 2019 | 8 | 0.160 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 86 | 0.160 |
Why?
|
| Bias | 1 | 2020 | 132 | 0.160 |
Why?
|
| Epilepsy, Generalized | 1 | 2020 | 64 | 0.160 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2019 | 17 | 0.160 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2021 | 658 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2021 | 344 | 0.160 |
Why?
|
| Sequence Deletion | 2 | 2018 | 528 | 0.160 |
Why?
|
| Coloboma | 1 | 2019 | 45 | 0.160 |
Why?
|
| Nerve Degeneration | 1 | 2020 | 121 | 0.160 |
Why?
|
| Ataxia | 4 | 2022 | 169 | 0.150 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2018 | 7 | 0.150 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 605 | 0.150 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2018 | 133 | 0.150 |
Why?
|
| Genes | 1 | 2019 | 447 | 0.150 |
Why?
|
| Cataract | 2 | 2021 | 224 | 0.150 |
Why?
|
| Base Sequence | 3 | 2018 | 3109 | 0.150 |
Why?
|
| Hypoglycemia | 1 | 2020 | 191 | 0.150 |
Why?
|
| Sphingomyelins | 1 | 2018 | 14 | 0.150 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 20 | 0.150 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 260 | 0.150 |
Why?
|
| DiGeorge Syndrome | 1 | 2018 | 80 | 0.140 |
Why?
|
| Neurodegenerative Diseases | 2 | 2017 | 249 | 0.140 |
Why?
|
| Peroxisomal Biogenesis Factor 2 | 1 | 2017 | 4 | 0.140 |
Why?
|
| Retina | 1 | 2020 | 452 | 0.140 |
Why?
|
| T-Box Domain Proteins | 1 | 2018 | 115 | 0.140 |
Why?
|
| Protein Subunits | 1 | 2018 | 165 | 0.140 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2022 | 399 | 0.140 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2017 | 67 | 0.140 |
Why?
|
| Axons | 1 | 2020 | 371 | 0.140 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2018 | 158 | 0.140 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2016 | 13 | 0.130 |
Why?
|
| Cerebellar Ataxia | 1 | 2017 | 66 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2022 | 4821 | 0.130 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 148 | 0.130 |
Why?
|
| Genes, Recessive | 1 | 2017 | 184 | 0.130 |
Why?
|
| Liver Transplantation | 1 | 2024 | 1042 | 0.130 |
Why?
|
| RNA Interference | 2 | 2014 | 508 | 0.120 |
Why?
|
| Sequence Alignment | 2 | 2021 | 620 | 0.120 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 210 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2022 | 858 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 359 | 0.120 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 933 | 0.120 |
Why?
|
| GTP-Binding Proteins | 1 | 2016 | 179 | 0.120 |
Why?
|
| Animals, Genetically Modified | 3 | 2023 | 312 | 0.120 |
Why?
|
| Aortic Aneurysm | 1 | 2018 | 231 | 0.120 |
Why?
|
| Protein Domains | 1 | 2016 | 236 | 0.120 |
Why?
|
| Escherichia coli | 1 | 2020 | 968 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 274 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 436 | 0.110 |
Why?
|
| Proteins | 1 | 2019 | 1040 | 0.110 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 135 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 1316 | 0.110 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 479 | 0.110 |
Why?
|
| Autophagy | 1 | 2016 | 395 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1130 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2025 | 2654 | 0.100 |
Why?
|
| Middle Aged | 5 | 2024 | 26676 | 0.100 |
Why?
|
| Disease | 1 | 2014 | 129 | 0.100 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2014 | 75 | 0.100 |
Why?
|
| Endoplasmic Reticulum | 2 | 2024 | 217 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2018 | 1035 | 0.100 |
Why?
|
| Glucose | 1 | 2017 | 876 | 0.100 |
Why?
|
| Registries | 4 | 2022 | 1434 | 0.100 |
Why?
|
| Mice | 5 | 2024 | 17740 | 0.100 |
Why?
|
| Intussusception | 1 | 2013 | 48 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 682 | 0.100 |
Why?
|
| Mammals | 2 | 2024 | 257 | 0.100 |
Why?
|
| Software | 1 | 2017 | 687 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2019 | 827 | 0.100 |
Why?
|
| Computational Biology | 1 | 2017 | 819 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 963 | 0.090 |
Why?
|
| Premature Birth | 2 | 2007 | 388 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 356 | 0.090 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 1 | 2011 | 14 | 0.090 |
Why?
|
| Leigh Disease | 1 | 2011 | 24 | 0.090 |
Why?
|
| Collagen Type XI | 1 | 2010 | 4 | 0.090 |
Why?
|
| Transcriptome | 1 | 2017 | 978 | 0.090 |
Why?
|
| Osteochondrodysplasias | 1 | 2010 | 66 | 0.080 |
Why?
|
| Lysine | 2 | 2023 | 200 | 0.080 |
Why?
|
| DNA, Mitochondrial | 1 | 2011 | 212 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 8 | 2 | 2020 | 11 | 0.080 |
Why?
|
| Face | 2 | 2022 | 179 | 0.080 |
Why?
|
| Aged | 2 | 2024 | 19656 | 0.070 |
Why?
|
| Haploinsufficiency | 2 | 2020 | 258 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 2527 | 0.070 |
Why?
|
| Neurons | 3 | 2021 | 1933 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 3898 | 0.060 |
Why?
|
| Databases, Genetic | 2 | 2019 | 475 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 1006 | 0.060 |
Why?
|
| Proteinuria | 1 | 2005 | 105 | 0.060 |
Why?
|
| Ovulation Induction | 1 | 2005 | 41 | 0.060 |
Why?
|
| Family Health | 1 | 2005 | 256 | 0.060 |
Why?
|
| Proprotein Convertases | 1 | 2024 | 22 | 0.060 |
Why?
|
| alpha-Fetoproteins | 1 | 2005 | 132 | 0.060 |
Why?
|
| Lipid Droplets | 1 | 2024 | 47 | 0.050 |
Why?
|
| Genes, X-Linked | 1 | 2024 | 59 | 0.050 |
Why?
|
| United States | 2 | 2018 | 10884 | 0.050 |
Why?
|
| Fertilization in Vitro | 1 | 2005 | 156 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2024 | 182 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2023 | 51 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2024 | 121 | 0.050 |
Why?
|
| Methylation | 1 | 2023 | 224 | 0.050 |
Why?
|
| Methyltransferases | 1 | 2023 | 72 | 0.050 |
Why?
|
| Vesicular Transport Proteins | 1 | 2024 | 120 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2023 | 101 | 0.050 |
Why?
|
| Phosphatidylinositols | 1 | 2022 | 31 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2024 | 219 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2005 | 761 | 0.050 |
Why?
|
| Calcium Channels, N-Type | 1 | 2022 | 24 | 0.050 |
Why?
|
| Eye Movements | 1 | 2022 | 71 | 0.050 |
Why?
|
| Ribonuclease III | 1 | 2022 | 93 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 227 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2022 | 463 | 0.050 |
Why?
|
| Polycomb-Group Proteins | 1 | 2021 | 19 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2022 | 402 | 0.050 |
Why?
|
| Pregnancy | 3 | 2018 | 7221 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 1425 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2022 | 90 | 0.050 |
Why?
|
| Neck | 1 | 2022 | 135 | 0.050 |
Why?
|
| Genes, Homeobox | 1 | 2021 | 71 | 0.040 |
Why?
|
| Research Personnel | 1 | 2022 | 117 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2022 | 236 | 0.040 |
Why?
|
| Reflex, Abnormal | 1 | 2020 | 16 | 0.040 |
Why?
|
| Spine | 1 | 2021 | 140 | 0.040 |
Why?
|
| Logistic Models | 1 | 2005 | 1800 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2020 | 244 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2024 | 368 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2020 | 116 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2020 | 89 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 283 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2021 | 445 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2019 | 63 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 352 | 0.040 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2005 | 972 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 670 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 152 | 0.040 |
Why?
|
| Age of Onset | 1 | 2020 | 600 | 0.040 |
Why?
|
| Transcription Initiation, Genetic | 1 | 2018 | 8 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2025 | 1053 | 0.040 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2018 | 53 | 0.040 |
Why?
|
| Infant Care | 1 | 2017 | 47 | 0.040 |
Why?
|
| Corpus Callosum | 1 | 2018 | 98 | 0.040 |
Why?
|
| United Kingdom | 1 | 2018 | 190 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 810 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2018 | 170 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 278 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2017 | 124 | 0.030 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2017 | 31 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 1237 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2018 | 187 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2022 | 1172 | 0.030 |
Why?
|
| Ketoglutaric Acids | 1 | 2016 | 24 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2018 | 108 | 0.030 |
Why?
|
| Genitalia | 1 | 2016 | 36 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2019 | 490 | 0.030 |
Why?
|
| Speech Disorders | 1 | 2016 | 43 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2023 | 2814 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 456 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 414 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1756 | 0.030 |
Why?
|
| Brain | 2 | 2019 | 3014 | 0.030 |
Why?
|
| Hypertension | 1 | 2005 | 1286 | 0.030 |
Why?
|
| Lysosomes | 1 | 2018 | 239 | 0.030 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2015 | 4 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2017 | 224 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2017 | 202 | 0.030 |
Why?
|
| Point Mutation | 1 | 2017 | 351 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2016 | 166 | 0.030 |
Why?
|
| Retinal Dystrophies | 1 | 2015 | 6 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 1284 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2016 | 168 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2018 | 680 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2018 | 371 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2016 | 257 | 0.030 |
Why?
|
| Pupa | 1 | 2014 | 21 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2017 | 343 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 528 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2021 | 16338 | 0.030 |
Why?
|
| Genotype | 1 | 2019 | 2569 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 426 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3728 | 0.030 |
Why?
|
| Cognition | 1 | 2018 | 724 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 368 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1893 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 3600 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1395 | 0.020 |
Why?
|
| Precision Medicine | 1 | 2015 | 321 | 0.020 |
Why?
|
| Algorithms | 1 | 2019 | 1630 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 656 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 1306 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4683 | 0.020 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2011 | 23 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3402 | 0.020 |
Why?
|
| Risk Factors | 1 | 2005 | 10278 | 0.020 |
Why?
|
| Cartilage | 1 | 2010 | 48 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 256 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 295 | 0.020 |
Why?
|
| Hearing Loss | 1 | 2010 | 136 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 3571 | 0.020 |
Why?
|
| Neoplasms | 1 | 2023 | 2794 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 1265 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 819 | 0.020 |
Why?
|
| Missouri | 1 | 2007 | 36 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6537 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 1833 | 0.020 |
Why?
|
| Blastomeres | 1 | 2005 | 6 | 0.010 |
Why?
|
| Embryo Transfer | 1 | 2005 | 58 | 0.010 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2005 | 44 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 945 | 0.010 |
Why?
|
| Recurrence | 1 | 2007 | 1390 | 0.010 |
Why?
|
| Gestational Age | 1 | 2007 | 1169 | 0.010 |
Why?
|